Automated Production of Plant-Based Vaccines and Pharmaceuticals

2012 Matthews, 2006, Egg-Based Production of Influenza Vaccine: 30 Years of Commercial Experience, The Bridge, 36, 17 Scannon, 2006, Pharmaceutical Preparedness for a Pandemic, The Bridge, 36, 10 Fedson, 2008, NEW Technologies for Meeting the Global Demand for Pandemic Influenza Vaccines, Biologicals, 36, 346, 10.1016/j.biologicals.2008.07.001 Gerdil, 2003, The Annual Production Cycle for Influenza Vaccine, Vaccine, 21, 1776, 10.1016/S0264-410X(03)00071-9 Tremblay, 2010, Tobacco, a Highly Efficient Green Bioreactor for Production of Therapeutic Proteins, Biotechnol. Adv, 28, 214, 10.1016/j.biotechadv.2009.11.008 Obembe, 2011, Advances in Plant Molecular Farming, Biotechnol. Adv, 29, 210, 10.1016/j.biotechadv.2010.11.004 Yusibov, 2011, Clinical Development of Plant-Produced Recombinant Pharmaceuticals: Vaccines, Antibodies and Beyond, Hum. Vaccin, 7, 313, 10.4161/hv.7.3.14207 Ma, 2003, The Production of Recombinant Pharmaceutical Proteins in Plants, Nat. Rev. Genet, 4, 794, 10.1038/nrg1177 Horn, 2004, Plant Molecular Farming: Systems and Products, Plant Cell Rep, 22, 711, 10.1007/s00299-004-0767-1 D’Aoust, 2010, The Production of Hemagglutinin-Based Virus-Like Particles in Plants: A Rapid, Efficient and Safe Response to Pandemic Influenza, Plant Biotechnol. J, 8, 607, 10.1111/j.1467-7652.2009.00496.x Penney, 2011, Plant-Made Vaccines in Support of the Millennium Development Goals, Plant Cell Rep, 30, 789, 10.1007/s00299-010-0995-5 Shoji, 2012, A Plant-Based System for Rapid Production of Influenza Vaccine Antigens, Influenza Other Respi. Viruses, 6, 204, 10.1111/j.1750-2659.2011.00295.x Jul-Larsen, 2012, The Human Potential of a Recombinant Pandemic Influenza Vaccine Produced in Tobacco Plants, Hum. Vaccin. Immunother, 8, 653, 10.4161/hv.19503